M&T BANK CORP (MTB) is held by 3 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 3 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $5.2M sold). Latest close $214.17 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Oct 16, 2026 · Congress to Nov 16, 2026.
Matrix Asset Advisors · Ariel Investments · Davis Advisors — 3 tracked funds hold MTB. See all holders.
Insiders bought on the open market (0 purchases, $0) vs 3 sales ($5.2M). Insider trading
CVS HEALTH Corp (CVS) · BANK OF AMERICA CORP /DE/ (BAC) · CAPITAL ONE FINANCIAL CORP (COF) · Bank of New York Mellon Corp (BNY) · Itau Unibanco Holding S.A. (ITUB) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Matrix Asset Advisors | 1.52% | 78,790 | HELD Q3 filed Oct 13 |
| Ariel Investments | 0.41% | 174,574 | TRIMMED (-1.7%) Q3 filed Nov 13 |
| Davis Advisors | 0.06% | 58,072 | TRIMMED (-3.7%) Q3 filed Nov 10 |
| Giverny Capital | — | — | EXITED |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -10.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 1,153 of 8,857 filers |
| Long-only filers among them | 1,149 |
| Change vs 2026 Q1 | +64 net · 1,000 entered · 936 exited |
| Shares reported, all filers | 131,104,743 |
| Reported value, all filers | $30.8B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | State Commercial Banks (SIC 6022) |
| Revenue · FY2025 | $1.7B |
| Net income · FY2025 | $2.9B |
| Total assets · FY2025 | $213.5B |
| Shares outstanding | 144,416,262 |
| Market cap (at latest close) | $30.9B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.
| Shares short · Oct 15, 2026 | 5,194,887 |
| Share of shares outstanding | 3.60% |
| Days to cover | 5.18 |
Shares short at recent settlements — Jul 31, 2026: 5.3M · Aug 14, 2026: 5.6M · Aug 31, 2026: 5.6M · Sep 15, 2026: 5.2M · Sep 30, 2026: 5.1M · Oct 15, 2026: 5.2M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 3 sales by 3 insiders ($5.2M).
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | PEARSON KEVIN J | Vice Chairman | Sell | 2,000 | $220.75 | $441.5K | SEC filing |
| Sep 14, 2026 | JONES RENE F | Chairman of the Board and CEO | Sell | 19,396 | $239.35 | $4.6M | SEC filing |
| Aug 21, 2026 | Seseri Rudina | Sell | 623 | $241.04 | $150.2K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | JONES RENE F | Officer, Director | 19,396 | $4.6M | Sep 14, 2026 | SEC filing |
| Aug 21, 2026 | Seseri Rudina | Director | 623 | $150.2K | Aug 21, 2026 | SEC filing |
| Aug 17, 2026 | Taylor John R. | Officer | 1,217 | $308.9K | Aug 17, 2026 | SEC filing |
| Aug 3, 2026 | Ledgett Richard H. Jr. | Director | 855 | $212.2K | Aug 3, 2026 | SEC filing |
| Jul 16, 2026 | GEISEL GARY N | Former Director | 1,259 | $318.5K | Jul 16, 2026 | SEC filing |
| Jul 15, 2026 | PEARSON KEVIN J | Officer | 2,000 | $484.0K | Jul 15, 2026 | SEC filing |
| Jul 1, 2026 | Woodrow Tracy S. | Officer | 881 | $213.2K | Jul 1, 2026 | SEC filing |
| Jun 15, 2026 | M&T Bank Corporation Pension Plan | Affiliate | 63,000 | $14.8M | Jun 15, 2026 | SEC filing |
| Jun 15, 2026 | Taylor John R. | Officer | 1,098 | $256.1K | Jun 15, 2026 | SEC filing |
| Jun 10, 2026 | GEISEL GARY N | Director | 1,200 | $273.3K | Jun 10, 2026 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Vanguard Portfolio Management | SC 13G/A | 7,102,697 | 4.8% | Jun 30, 2026 | SEC filing |
| Apr 30, 2026 | Vanguard Capital Management | SC 13G | 11,332,373 | 7.6% | Mar 31, 2026 | SEC filing |
| Apr 29, 2026 | Vanguard Portfolio Management | SC 13G | 7,512,503 | 5.0% | Mar 31, 2026 | SEC filing |
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 5, 2026 | FMR LLC | SC 13G/A | 13,300,901.57 | 8.7% | Dec 31, 2025 | SEC filing |
| May 13, 2025 | STATE STREET CORPORATION | SC 13G | 8,058,474 | 4.9% | Mar 31, 2025 | SEC filing |
| May 12, 2025 | Wellington Management Group LLP | SC 13G | 9,894,065 | 6.0% | Mar 31, 2025 | SEC filing |
| May 12, 2025 | FMR LLC | SC 13G/A | 11,986,746.12 | 7.3% | Mar 31, 2025 | SEC filing |
| Feb 12, 2025 | FMR LLC | SC 13G/A | 14,071,757.34 | 8.5% | Dec 31, 2024 | SEC filing |
| Feb 10, 2025 | Wellington Management Group LLP | SC 13G/A | 7,433,750 | 4.5% | Dec 31, 2024 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: State Commercial Banks (SIC 6022). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 288 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Banking (139), Taxation/Internal Revenue Code (85), Financial Institutions/Investments/Securities (80).
Federal contracts: $908.5K in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $0 |
| FY2022 | $473.5K |
| FY2023 | $0 |
| FY2024 | $435.0K |
| FY2025 | $0 |
| FY2026 | $0 |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| 33314518P00388676 | Smithsonian Institution | $853.8K | Nov 3, 2017 |
| 33314522P00469052 | Smithsonian Institution | $665.0K | Jan 26, 2022 |
| 33314520P00436150 | Smithsonian Institution | $390.2K | Dec 16, 2019 |
| 33314522P00462210 | Smithsonian Institution | $0 | Nov 24, 2021 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Financial Screens
· Dividend Growth — Dividends raised for more than 10 years
· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%
· Deep Value (Templeton) — Stocks that are cheap against both earnings and assets
· Neff Total Return Ratio — Growth plus dividends divided by P/E is high
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Shareholder Yield — Cash returned through dividends and buybacks
· Earnings Stability — Small earnings swings and almost no loss years
Key figures
· Dividend Growth — Dividend per share: 5.70 · Dividend yield: 2.5% · Straight dividend years: 11 · 10-yr dividend growth: 103.6%
· Cash Flow (FCF) — Latest FCF: $3.6B · FCF yield: 10.3% · Positive FCF years: 3
· Deep Value (Templeton) — P/E: 13.18 · P/B: 1.22 · Latest EPS: 17 · Dividend yield: 2.5%
· Neff Total Return Ratio — EPS growth: 11.3% · Dividend yield: 2.5% · P/E: 13.18 · Neff ratio: 1.05
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.29 · Operating cash flow: $3.0B · Net income: $2.9B
· Shareholder Yield — Shareholder yield: 9.9% · of which dividends: 2.5% · of which buybacks: 7.4%
· Earnings Stability — Earnings variation (CV): 0.27 · Loss years (of 10): 0 · Latest net income: $2.9B
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 10 | 50.0% | +8.2% | +1.9% | +6.3% |
| Share count tripled (3x) | 2 | 50.0% | +10.3% | -2.7% | +12.9% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold MTB — ranked by lift, the co-holding pattern described in Methodology: CVS HEALTH Corp (CVS) · BANK OF AMERICA CORP /DE/ (BAC) · CAPITAL ONE FINANCIAL CORP (COF) · Bank of New York Mellon Corp (BNY) · Itau Unibanco Holding S.A. (ITUB) · STATE STREET CORP (STT) · Ally Financial Inc. (ALLY) · DEUTSCHE BANK AKTIENGESELLSCHAFT (DB).
5 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Oct 16, 2026 | 2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 28, 2026 | 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Sep 22, 2026 | 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
CVS HEALTH Corp (CVS) · Track Record: how the signals scored · Practice timing on MTB
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.